Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

Press/Media: Press / Media

Period	2024 Dec 2

Media coverage

Title	Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy
Media name/outlet	MEDI:GATE NEWS
Date	24/12/2
URL	https://www.medigatenews.com/news/576019755?category=english_news
Persons	Dong-Wan Kim